Microfluidics Fight Covid (CoronaVirus Disease)
Enabling detective, preventive, and curative technologies for COVID
Recognizing the danger of genome modification and reorganization
Submit Your Input
| Severity of SARS-CoV-2 Reinfections |
| Inactivated SARS-CoV-2 vaccine mimicked an infection. |
| Oral Covid-19 Treatment: Paxlovid, Molnupiravir, Antroquinonol, and S-217622. |
| The variants of COVID-19: concerns and studies. |
| Front Line COVID-19 Critical Care Alliance: Prevention & Treatment Protocols for COVID-19. |
| Studies and reports on early COVID-19 cases |
| Cepharanthine and Nelfinavir Are Effective at Combating SARS-CoV-2 in Cell Culture Models. |
| Rhinovirus infection may be able to block the growth of the SARS-CoV-2 virus. |
| Mandatory lockdowns may not be any better at controlling COVID-19. |
| Eli Lilly's monoclonal antibody for treating COVID-19: who is eligible and how to apply! |
| Moderna vs Pfizer_ Who will win the Covid-19 vaccine race? |
| President Trump received mostly the same treatment as anyone would get for COVID-19, only faster and one experimental drug. |
| Approach to COVID-19 recommended by Eastern Virginia Medical School and COVID-19 research methods from RayBiotech. |
| Saliva-Based COVID-19 Test Developed At Yale University Could Be A 'Game Changer'. |
| In getting protocol for preventing and treating early stage COVID-19 infection, SpeakWithAnMD.com may be the place to find a doctor. |
| In preventing and treating early stage COVID-19 infection, "Quercetin(500mg) + Zinc(50mg) + Vitamin C" daily is safer than hydroxychloroquine + azithromycin + Zinc. |
| Microtechnology-Enabled Solutions in Overcoming COVID-19 |
| COVID-19 losing virulence, Severity Variations of Covid-19, and Vitamin D Deficiency Causing Higher COVID-19 Mortality Rates. |
| Immunological Model of COVID-19, "Smoking and intensive activities should be avoided during the early stage of infection". |
| RLF-100 (aviptadil), Steroid dexamethasone, Remdesivir, and Ivermectin for treating SARS-Cov-2. |
| Gene Based Vaccines for COVID-19 and Pittsburgh CoronaVirus Vaccine (PittCoVacc) against SARS-CoV-2 |
| A very old drug is coming back to the fore. The successful testing of hydroxychloroquine and azithromycin for use against the coronavirus in France's second city Marseille on March 16 created high expectations amid this surging epidemic - especially in light of Donald Trump's announcement on Thursday that the US Food and Drug Administration has approved its use for this purpose. |
| The non-receptor dependent phagocytic general method AND phylogenetic network analysis of SARS-CoV-2 genomes. |
| China Concealed Coronavirus Outbreak Extent: U.S. Intelligence, report by Bloomberg on April 1st, 2020. |
| Genomic epidemiology of hCoV-19 (Enabled by data from GISAID), showing 848 of 848 genomes sampled between Dec 2019 and Mar 2020 and comprising 5 recencys, 5 locations, 5 divisions, 5 countries, 5 hosts, 5 regions, 5 authors, 5 originating labs and 5 submitting labs. |
| Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins on Nature (2020). |
| The proximal origin and rapid reconstruction of SARS-CoV-2. |
| Virus research at Wuhan Institute of Virology and two articles on Nature (2013) and Nature Medicine (2015) studying New CoronaVirus. |
| Whistle Blower of COVID-19 |
| A summary of a talk about COVID-19 on March 10, 2020. |
| The 2019-20 coronavirus outbreak is an ongoing global outbreak of coronavirus disease 2019 that has been declared a Public Health Emergency of International Concern. |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known by the provisional name 2019 novel coronavirus (2019-nCoV), is a positive-sense single-stranded RNA virus. |